Applicants,Chemical_Name,Funding_requested_for,Pharmaceutical,Priority_List,Schedules,Therapeutic_group
JUNIPER BIOLOGICS PTY LTD,Netupitant/palonosetron,Prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of moderately emetogenic anti-cancer treatments.,Netupitant/palonosetron (Akynzeo),Recommended for decline,Community and Hospital,
